Dr. Choe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
400 W 12th Ave
Columbus, OH 43210Phone+1 614-293-2268Fax+1 614-293-7526- Is this information wrong?
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2014 - 2017
University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 2011 - 2014
Indiana University School of MedicineClass of 2011
Certifications & Licensure
CA State Medical License 2013 - Present
OH State Medical License 2017 - 2025
NY State Medical License 2014 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002) Start of enrollment: 2022 Jun 16
Roles: Contact
- Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD Start of enrollment: 2022 Apr 19
Roles: Sponsor-Investigator, Principal Investigator, Contact
- High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant Start of enrollment: 2020 Feb 07
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsA Day 14 Endpoint for Acute GVHD Clinical Trials.Al Malki, M. M., Nikolaos Spyrou, Yu Akahoshi, Steven Kowalyk, George Morales, Rahnuma Beheshti, Paibel Aguayo-Hiraldo, Monzr M Al Malki, Francis Ayuk, Peter Bader, Ja...> ;Transplantation and Cellular Therapy. 2024 Apr 1
- 1 citationsA randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adults.Pooja Khandelwal, Lucille Langenberg, Nathan Luebbering, Kelly E Lake, Abigail Butcher, Kylie Bota, Kristie N Ramos, Cynthia Taggart, Hannah Choe, Sumithira Vasu, Ashl...> ;Blood. 2024 Mar 21
- CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model.Neidemire-Colley, L., Khanal, S., Braunreiter, K., Gao, Y., Kumar, R., Snyder, K., Weber, M., Surana, S., Toirov, O., Karunasiri, M., Duszynski, M., Chi, M., Malik, P....> ;Blood Advances. 2024 Feb 27
- Join now to see all
Abstracts/Posters
- Effect of Early Post Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell TransplantationHannah K. Choe, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host DiseaseHannah K. Choe, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Bromodomain and Extraterminal (BET) Domain Inhibition with PLX51107 and PLX2853 Improves Survival and Decreases Acute GVHD Severity in Murine Models61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- PRMT5 Is Upregulated in Activated T Cells and Is a Novel Therapeutic Target for Acute Gvhd2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Actinium Highlights Ability of Iomab-B to Overcome High-Risk TP53 Mutation Resulting in Significant Improvement in Overall Survival in Patients with Active Relapsed Refractory AML at the European Bone Marrow Transplant Annual MeetingApril 19th, 2024
Hospital Affiliations
The OSUCCC - JamesColumbus, Ohio
Ohio State University Wexner Medical CenterColumbus, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
